Annexon Inc logo

ANNX

Annexon Inc

$5.57

Earnings Summary

Revenue
$0Mn
Net Profits
$-35.37Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Annexon Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Annexon Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Annexon Inc’s net profit fell -36.02% since last year same period to $-35.37Mn in the Q1 2022. On a quarterly growth basis, Annexon Inc has generated 72.86% jump in its net profits since last 3-months.

Net Profit Margins:

Annexon Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2022. On a quarterly growth basis, Annexon Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Annexon Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.94
EPS Estimate Current Year
-0.94

Highlights

EPS Estimate Current Quarter:

Annexon Inc’s earning per share (EPS) estimates for the current quarter stand at -0.94 - a 6% jump from last quarter’s estimates.

EPS Estimate Current Year:

Annexon Inc’s earning per share (EPS) estimates for the current year stand at -0.94.

Key Ratios

Key ratios of the Annexon Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.92
Return on Assets (ROA)
-0.33
Return on Equity (ROE)
-0.63
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Annexon Inc’s earning per share (EPS) fell -35.29% since last year same period to -0.92 in the Q1 2022. This indicates that the Annexon Inc has generated -35.29% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Annexon Inc’s return on assets (ROA) stands at -0.33.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Annexon Inc’s return on equity (ROE) stands at -0.63.

Dividend Per Share (DPS):

Annexon Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-09
-1
-0.92
8%

Company Information

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a rigorous, biomarker-driven development strategy designed to improve the probability of technical success over shorter development timelines.

Organisation
Annexon Inc
Employees
48
Industry
Health Technology